RT Journal Article
SR Electronic
T1 Pregnancy outcomes and long-term patient and graft survival after kidney transplantation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.18.22269382
DO 10.1101/2022.01.18.22269382
A1 Radaelli, Eloísa
A1 Meinerz, Gisele
A1 Jacobina, Lázaro Pereira
A1 Bruno, Rosana Mussoi
A1 Garcia, Valter Duro
A1 Stefani, Eduarda Tanus
A1 Lima, Letícia Kortz Motta
A1 Weber, Natália Klaus
A1 Keitel, Elizete
YR 2022
UL http://medrxiv.org/content/early/2022/01/21/2022.01.18.22269382.abstract
AB Introduction Kidney transplant is considered the method of choice in the treatment of end-stage chronic kidney disease, improving survival and quality of life, and often allowing the recovery of fertility among woman. Objective: This study aims to assess the outcomes of post-transplant pregnancy, newborn and patient graft survival, compared to a control group of transplanted women who weren’t pregnant.Methods A retrospective case-control study was conducted at the Kidney Transplant Service of Santa Casa de Misericórdia in Porto Alegre, among 1.253 female patients who underwent kidney transplantation and were of childbearing age between 1977 and 2016. They were compared to a control group matched for age, type of donor, date of transplant and immunological risk.Results 76 (6,1%) of the patients became pregnant, resulting in a total of 93 pregnancies. Compared to the control group, at 10 years after transplantation there was no significant difference in relation to graft loss (74% vs 66%, p=0.524), and the survival of pregnant patients was higher (97% vs 79%, p=0.018). We found that 40% pregnancies progressed to abortion, 30% of the deliveries were preterm, and 26% happened at term. Three pregnancies progressed to stillbirth. Of the 56 pregnancies that evolved, 23 (41%) resulted in pre-eclampsia, and one in eclampsia.Conclusion 6,1% of the women in the study became pregnant, and 56% of these pregnancies were successful. Compared to the control group, we found that those who got pregnant had similar graft survival outcomes and longer patient survival.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Irmandade da Santa Casa de Misericordia de Porto Alegre - ISCMPA gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors